Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.
作者信息
Walker M C, Li L M, Sander J W
机构信息
Institute of Neurology, National Hospital for Neurology and Neurosurgery, London.
出版信息
BMJ. 1996 Nov 9;313(7066):1184-5. doi: 10.1136/bmj.313.7066.1184.
Abstract
摘要
相似文献
1
Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.拉莫三嗪和氨己烯酸在严重难治性癫痫中的长期应用：疗效审计
BMJ. 1996 Nov 9;313(7066):1184-5. doi: 10.1136/bmj.313.7066.1184.
2
[New antiepileptic drugs: vagabatrin, lamotrigine and felbamate].新型抗癫痫药物：氨己烯酸、拉莫三嗪和非氨酯
Neurologia. 1994 Nov;9(9):410-7.
3
A survey comparing lamotrigine and vigabatrin in everyday clinical practice.一项在日常临床实践中比较拉莫三嗪和氨己烯酸的调查。
Seizure. 1996 Dec;5(4):267-70. doi: 10.1016/s1059-1311(96)80019-7.
4
Combination vigabatrin and lamotrigine therapy for intractable epilepsy.联合使用氨己烯酸和拉莫三嗪治疗难治性癫痫。
Seizure. 1996 Mar;5(1):51-6. doi: 10.1016/s1059-1311(96)80063-x.
5
New antiepileptic drugs already registered.已注册的新型抗癫痫药物。
Epilepsia. 1994;35 Suppl 5:S22-4. doi: 10.1111/j.1528-1157.1994.tb05961.x.
6
The new antiepileptic drugs.新型抗癫痫药物。
Arch Dis Child. 1996 Sep;75(3):256-62. doi: 10.1136/adc.75.3.256.
7
Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
Epilepsia. 1998 Aug;39(8):878-83. doi: 10.1111/j.1528-1157.1998.tb01184.x.
8
New antiepileptic drugs for children: felbamate, gabapentin, lamotrigine, and vigabatrin.儿童新型抗癫痫药物：非氨酯、加巴喷丁、拉莫三嗪和氨己烯酸。
J Child Neurol. 1994 Oct;9 Suppl 1:S33-45. doi: 10.1177/0883073894009001071.
9
[Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].[氨己烯酸和拉莫三嗪：瑞士癫痫诊所两种新型抗惊厥药物的使用经验]
Schweiz Med Wochenschr. 1995 Jan 28;125(4):125-32.
10
Adjunctive therapy in epilepsy: a cost-effectiveness comparison of alternative treatment options.癫痫的辅助治疗：替代治疗方案的成本效益比较
Seizure. 1995 Mar;4(1):37-44. doi: 10.1016/s1059-1311(05)80076-7.
引用本文的文献
1
Dropout rates with olanzapine or risperidone: a multi-centre observational study.
Eur J Clin Pharmacol. 2004 Feb;59(12):905-9. doi: 10.1007/s00228-003-0705-0. Epub 2003 Dec 19.
2
The promise of new antiepileptic drugs.新型抗癫痫药物的前景。
Br J Clin Pharmacol. 2002 Feb;53(2):123-31. doi: 10.1046/j.0306-5251.2001.01540.x.
3
Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic.托吡酯在临床实践中的应用：专科癫痫诊所获批上市后第一年的经验
J Neurol Neurosurg Psychiatry. 1999 Jun;66(6):759-63. doi: 10.1136/jnnp.66.6.759.
4
The need for pharmacoeconomic evaluations in the NHS.英国国家医疗服务体系（NHS）中药物经济学评估的必要性。
Pharmacoeconomics. 1998 Sep;14(3):241-50. doi: 10.2165/00019053-199814030-00001.
5
Newly licensed drugs.新获批药物。
BMJ. 1996 Nov 9;313(7066):1157-8. doi: 10.1136/bmj.313.7066.1157.
6
Drug trials in epilepsy.癫痫药物试验
BMJ. 1996 Nov 9;313(7066):1158. doi: 10.1136/bmj.313.7066.1158.
本文引用的文献
1
Mortality in patients with epilepsy: a study of patients in long term residential care.癫痫患者的死亡率：一项针对长期住院护理患者的研究。
J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):149-52. doi: 10.1136/jnnp.56.2.149.
2
Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre.在一家三级转诊中心的成人癫痫门诊队列中意外猝死的发生率。
J Neurol Neurosurg Psychiatry. 1995 Apr;58(4):462-4. doi: 10.1136/jnnp.58.4.462.
3
The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy.拉莫三嗪治疗严重癫痫的疗效及长期耐受性
Epilepsy Res. 1990 Dec;7(3):226-9. doi: 10.1016/0920-1211(90)90019-r.
Zotero 插件